Cat. No. |
Product Name |
Information |
PC-38478 |
KYP-2047
Prolyl oligopeptidase (PREP) inhibitor
|
KYP-2047 is a high affinity prolyl oligopeptidase (PREP) inhibitor with Ki of 0.023 nM, reduces α-synuclein protein levels and aggregates in cellular and animal models of PD. |
PC-38445 |
ML180
LRH1 (NR5A2) inhibitor
|
ML180 (SR1848) is a potent, selective Liver Receptor Homologue-1 (LRH1, NR5A2) inverse agonist with IC50 of 3.7 uM in reporter assays, displays no activity against SF1 (NR5A1). |
PC-38444 |
ML179
LRH1 (NR5A2) inhibitor
|
ML179 (SR1309) is a potent, selective Liver Receptor Homologue-1 (LRH1, NR5A2) inverse agonist with IC50 of 320 nM in reporter assays, displays no activity against SF1 (NR5A1). |
PC-38436 |
NEK7 inhibitor M12
NEK7 inhibitor
|
NEK7 inhibitor M12 is a novel potent inhibitor of NEK7 protein, inhibits cell viability of human HepG2 liver cancer cells. |
PC-38425 |
Utreloxastat
α-synuclein inhibitor
|
Utreloxastat is a small molecule with potential for suppressing and treating α-synucleinopathies, tauopathies, and other disorders. |
PC-38422 |
Sirpiglenastat
Glutamine antagonist
|
DRP-104 (Sirpiglenastat) is a novel broad acting glutamine antagonist, has significant anticancer activity by directly targeting tumor metabolism and simultaneously inducing a potent antitumor immune response. |
PC-38412 |
Phevamine A
Virulence factor
|
Phevamine A is a widely distributed virulence factor in phytopathogens, Phevamine A promotes bacterial growth by suppressing plant immune responses. |
PC-38411 |
BRD8518
TRIB1 inducer
|
BRD8518 is a specific small molecule TRIB1 inducer, modulates expression of the key genes involved in VLDL production and in LDL clearance in HepG2 cells. |
PC-38410 |
BRD0418
TRIB1 inducer
|
BRD0418 is a specific small molecule that upregulate TRIB1 expression and phenocopy the effects of TRIB1 cDNA overexpression (EC50=1 uM, TRIB1 overexpression in HepG2 cells). |
PC-38407 |
RJW100
LRH-1 (NR5A2) agonist
|
RJW100 (RJW 100) is a phospholipid mimetic as liver receptor homolog-1 (LRH-1, NR5A2) agonist with pEC50 of 6.6 and 7.5 for (LRH-1) and steroidogenic factor-1 (SF-1, NR5A1), respectively. |
PC-38400 |
Inaxaplin
APOL1 inhibitor
|
Inaxaplin (VX-147, VX147) is a small molecule inhibitor of apolipoprotein L1 (APOL1) channel function, shows potential for treatment of proteinuric kidney disease. |
PC-38392 |
Farudodstat
DHODH inhibitor
|
Farudodstat (ASLAN003) is a highly potent, selective dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 35 nM (human DHODH), significantly inhibits protein synthesis via activation AP-1 transcription, induces cell differentiation of AML cell lines. |